HighTower Advisors »

Madrigal Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $346k 1.5k 230.34
2022-12-31 $208k 720 288.89

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)

View all positions for HighTower Advisors

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Baker Bros. Advisors
venBio Select Advisor
Vanguard Group
Paulson & Co
T. Rowe Price Associates
Alliancebernstein
Artisan Partners Limited Partnership
Jane Street
AlpInvest Partners B.V.
RA Capital Management
Perceptive Advisors
Norges Bank Investment Management
Bank of America Corporation
Citadel Advisors

View all funds holding Madrigal Pharmaceuticals